New co-CEO named at WuXi; Bristol-Myers gets priority review for myeloma combo featuring Empliciti
→ Over the last 11 years, Edward Hu has been COO, CFO and chief investment officer at WuXi AppTec. Now he’s been named co-CEO, with a special responsibility for small molecule drug discovery, development, manufacturing services, drug and medical device testing services, plus some. He’s retaining his CFO responsibilities for now until a replacement is selected. And Hu will continue to report to company founder Ge Li, who’s been chiefly responsible for the rapid growth of the big China-based company.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.